Tennessee-based Chemical maker Eastman ChemicalEMN was downgraded to a Zacks Rank #3 (Hold) on May 24. The company recorded earnings of $278 million or $1.89 per share in the first quarter of 2017, higher than the year-ago figure of $251 million or $1.69.
Barring one-time items, earnings were $1.83 per share for the quarter that topped the Zacks Consensus Estimate of $1.74 per share.
Revenues rose around 2.9% year over year to $2.3 billion, beating the Zacks Consensus Estimate of $2.24 billion.
Eastman Chemical remains focused on cost-cutting and productivity actions amid a challenging operating environment, which are expected to contribute around 50 cents to earnings per share in 2017. Further, the company expects adjusted earnings per share to grow 8-12% in the year.
Eastman Chemical is also expected to gain from strategic acquisitions and capacity expansion actions. Moreover, the company remains committed to reduce debt and boost shareholders returns, leveraging healthy free cash flows. In 2017, it expects to generate solid free cash flow and return around $650 million to its shareholders.
Eastman Chemical's shares have gained 5.9% in the last six months, underperforming the Zacks categorized Chemicals-Diversified industry's gain of 9.1%.
However, pricing pressure continues to hurt the company's top-line. Challenging global economic conditions are affecting some of the company's businesses. The company sees volume pressure in the Fibers business in first-half 2017 and a roughly 25% decline in earnings for the unit for full-year 2017. The company also faces currency translation risks given a strong U.S. dollar.
Eastman Chemical has witnessed four downward and three upward revisions for current quarter earnings over the past 30 days. However, the Zacks Consensus Estimate for second-quarter 2017 has remained stable at $1.89, over the past 30 days.
Eastman Chemical Company Price and Consensus
Eastman Chemical Company Price and Consensus | Eastman Chemical Company Quote
Stocks to Consider
Some better-ranked companies in the chemical space include BASF SE BASFY , The Chemours Company CC and Kronos Worldwide Inc KRO . All the three stocks sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here.
BASF has expected long-term growth of 8.6%.
Chemours has expected long-term growth of 15.5%.
Kronos has expected long-term growth of 5%.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look. See the pot trades we're targeting>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
BASF SE (BASFY): Free Stock Analysis Report
Eastman Chemical Company (EMN): Free Stock Analysis Report
Kronos Worldwide Inc (KRO): Free Stock Analysis Report
Chemours Company (The) (CC): Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
